Dublin, June 25, 2024 (GLOBE NEWSWIRE) -- The "Global Amniocentesis Needle Market - Forecasts from 2024 to 2029" report has been added to ResearchAndMarkets.com's offering
The global medical community is observing a notable rise in the demand for amniocentesis needles, fueled by advancements in prenatal diagnostics and the growing need to test for fetal abnormalities during pregnancy. The amniocentesis needle market is poised for growth, projected to reach a valuation of US$214.857 million by 2029, growing at a CAGR of 2.07% during the forecast period from 2024 to 2029.
The increasing global population and a surge in pregnancies have catalyzed the demand for amniocentesis needles. Countries with significant population booms, such as China and India, are anticipated to contribute robustly to the market's growth due to the critical role of amniocentesis in prenatal diagnostics. As parents and healthcare systems prioritize fetal health, the procedure's importance in identifying and addressing genetic disorders and anomalies early in pregnancy is increasingly recognized.
Technological Innovations Propel Market Growth
Technological advancements have significantly impacted the amniocentesis needle market, making procedures safer and more reliable. Continuous research and development—supported by government investment in the healthcare sector—are leading to improved medical devices. These advancements bolster public trust in prenatal diagnostic procedures, facilitating market growth.
North America Leads in Market Expansion The North American region is expected to experience substantial growth within the amniocentesis needle market. The United States and Canada are at the forefront of medical and healthcare innovations, with numerous companies dedicated to creating high-quality medical equipment. Additionally, the tendency for delayed childbirth in North America heightens the need for impactful prenatal testing, further contributing to the growth of the amniocentesis needle market.
Market Challenges: Cost and Potential Risks
Despite significant growth prospects, the market faces challenges, including the high expense of procedures and risks of fetal injury. Such concerns might deter prospective parents from opting for these diagnostics, potentially restraining market expansion.
Meticulous Market Segmentation
The market is segmented by needle size, end-user, and geography, allowing for a granular analysis of trends and demands across various spectrums. Hospitals, diagnostic centers, and clinics are among the primary end-users for amniocentesis needles. Geographically, the market extensively covers regions including North America, South America, Europe, the Middle East and Africa, and Asia Pacific.
In conclusion, the amniocentesis needle market is experiencing a significant phase of growth, with positive forecasts leading into 2029. Advances in medical technology and increasing awareness of the importance of prenatal diagnostics are driving this upward trend, which shows promise for the health of mothers and babies worldwide.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 122 |
| Forecast Period | 2022 - 2029 |
| Estimated Market Value (USD) in 2022 | $186.32 Million |
| Forecasted Market Value (USD) by 2029 | $214.86 Million |
| Compound Annual Growth Rate | 2.0% |
| Regions Covered | Global |
Companies Featured
- Cook Medical Incorporated
- RI.MOS. Medical Products
- Medline Industries Inc.
- Biopsybell
- Cooper Surgical
- Germanos Medicals
- Obex Medical
- Science Equip Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/599041
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
